Background: Although lung cancer with ALK or ROS-1 gene fusion is rare, antitumor effect by ALK inhibitor can be highly expected. However, details of drug-induced lung injury (DILI), which can be serious side effect, remain unclear. Conclusion: Elderly people and lower renal function may require caution of DILI caused by ALK inhibitor. Images findings were subjected to OP pattern. The clinical course was not probably critical. READ ARTICLE
European Respiratory Journal DOI:10.1183/13993003.congress-2019.PA4734
Authors: Ken Koshikawa, Jiro Terada, Mitsuhiro Abe, Shunichiro Iwasawa, Masashi Sakayori, Kenji Tsushima, Koichiro Tatsumi